Last updated on August 2019

Evaluation of SPN-812 ER High Dose in Adolescents With ADHD


Brief description of study

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old)

Clinical Study Identifier: TX200768

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.